Non Hodgkin Lymphoma (NHL) Market, Global Outlook and Forecast 2022-2028

March 2022 | 68 pages | ID: N25F838ACB6FEN
Market Monitor Global

Abstracts

Non-Hodgkin Lymphoma is the most common lymphoma which affects large number of people. It begins in lymphocytes present in lymph nodes of body parts such as neck or chest or under the arms. It widely spreads to the other lymph nodes and to other organs such as bone marrow, lungs, or liver.

This report contains market size and forecasts of Non Hodgkin Lymphoma (NHL) in Global, including the following market information:

Global Non Hodgkin Lymphoma (NHL) Market Revenue, 2017-2022, 2023-2028, ($ millions)

Global top five companies in 2021 (%)

The global Non Hodgkin Lymphoma (NHL) market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period.

The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.

Standard Segment to Reach $ Million by 2028, with a % CAGR in next six years.

The global key manufacturers of Non Hodgkin Lymphoma (NHL) include F. Hoffmann-La Roche, Johnson & Johnson, Merck, Bristol Myers Squibb, Celgene, Eli Lilly, GlaxoSmithKline and Bayer, etc. In 2021, the global top five players have a share approximately % in terms of revenue.

MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Non Hodgkin Lymphoma (NHL) companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.

Total Market by Segment:

Global Non Hodgkin Lymphoma (NHL) Market, by Type, 2017-2022, 2023-2028 ($ millions)

Global Non Hodgkin Lymphoma (NHL) Market Segment Percentages, by Type, 2021 (%)

• Standard
• Exellent

Global Non Hodgkin Lymphoma (NHL) Market, by Application, 2017-2022, 2023-2028 ($ millions)

Global Non Hodgkin Lymphoma (NHL) Market Segment Percentages, by Application, 2021 (%)

• Hosptial
• Clinic

Global Non Hodgkin Lymphoma (NHL) Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions)

Global Non Hodgkin Lymphoma (NHL) Market Segment Percentages, By Region and Country, 2021 (%)

• North America
• US
• Canada
• Mexico
• Europe
• Germany
• France
• U.K.
• Italy
• Russia
• Nordic Countries
• Benelux
• Rest of Europe
• Asia
• China
• Japan
• South Korea
• Southeast Asia
• India
• Rest of Asia
• South America
• Brazil
• Argentina
• Rest of South America
• Middle East & Africa
• Turkey
• Israel
• Saudi Arabia
• UAE
• Rest of Middle East & Africa

Competitor Analysis

The report also provides analysis of leading market participants including:

Key companies Non Hodgkin Lymphoma (NHL) revenues in global market, 2017-2022 (estimated), ($ millions)

Key companies Non Hodgkin Lymphoma (NHL) revenues share in global market, 2021 (%)

Further, the report presents profiles of competitors in the market, key players include:

• F. Hoffmann-La Roche
• Johnson & Johnson
• Merck
• Bristol Myers Squibb
• Celgene
• Eli Lilly
• GlaxoSmithKline
• Bayer

Contents

1 INTRODUCTION TO RESEARCH & ANALYSIS REPORTS

1.1 Non Hodgkin Lymphoma (NHL) Market Definition
1.2 Market Segments
  1.2.1 Market by Type
  1.2.2 Market by Application
1.3 Global Non Hodgkin Lymphoma (NHL) Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
  1.5.1 Research Methodology
  1.5.2 Research Process
  1.5.3 Base Year
  1.5.4 Report Assumptions & Caveats

2 GLOBAL NON HODGKIN LYMPHOMA (NHL) OVERALL MARKET SIZE

2.1 Global Non Hodgkin Lymphoma (NHL) Market Size: 2021 VS 2028
2.2 Global Non Hodgkin Lymphoma (NHL) Market Size, Prospects & Forecasts: 2017-2028
2.3 Key Market Trends, Opportunity, Drivers and Restraints
  2.3.1 Market Opportunities & Trends
  2.3.2 Market Drivers
  2.3.3 Market Restraints

3 COMPANY LANDSCAPE

3.1 Top Non Hodgkin Lymphoma (NHL) Players in Global Market
3.2 Top Global Non Hodgkin Lymphoma (NHL) Companies Ranked by Revenue
3.3 Global Non Hodgkin Lymphoma (NHL) Revenue by Companies
3.4 Top 3 and Top 5 Non Hodgkin Lymphoma (NHL) Companies in Global Market, by Revenue in 2021
3.5 Global Companies Non Hodgkin Lymphoma (NHL) Product Type
3.6 Tier 1, Tier 2 and Tier 3 Non Hodgkin Lymphoma (NHL) Players in Global Market
  3.6.1 List of Global Tier 1 Non Hodgkin Lymphoma (NHL) Companies
  3.6.2 List of Global Tier 2 and Tier 3 Non Hodgkin Lymphoma (NHL) Companies

4 MARKET SIGHTS BY PRODUCT

4.1 Overview
  4.1.1 by Type - Global Non Hodgkin Lymphoma (NHL) Market Size Markets, 2021 & 2028
  4.1.2 Standard
  4.1.3 Exellent
4.2 By Type - Global Non Hodgkin Lymphoma (NHL) Revenue & Forecasts
  4.2.1 By Type - Global Non Hodgkin Lymphoma (NHL) Revenue, 2017-2022
  4.2.2 By Type - Global Non Hodgkin Lymphoma (NHL) Revenue, 2023-2028
  4.2.3 By Type - Global Non Hodgkin Lymphoma (NHL) Revenue Market Share, 2017-2028

5 SIGHTS BY APPLICATION

5.1 Overview
  5.1.1 By Application - Global Non Hodgkin Lymphoma (NHL) Market Size, 2021 & 2028
  5.1.2 Hosptial
  5.1.3 Clinic
5.2 By Application - Global Non Hodgkin Lymphoma (NHL) Revenue & Forecasts
  5.2.1 By Application - Global Non Hodgkin Lymphoma (NHL) Revenue, 2017-2022
  5.2.2 By Application - Global Non Hodgkin Lymphoma (NHL) Revenue, 2023-2028
  5.2.3 By Application - Global Non Hodgkin Lymphoma (NHL) Revenue Market Share, 2017-2028

6 SIGHTS BY REGION

6.1 By Region - Global Non Hodgkin Lymphoma (NHL) Market Size, 2021 & 2028
6.2 By Region - Global Non Hodgkin Lymphoma (NHL) Revenue & Forecasts
  6.2.1 By Region - Global Non Hodgkin Lymphoma (NHL) Revenue, 2017-2022
  6.2.2 By Region - Global Non Hodgkin Lymphoma (NHL) Revenue, 2023-2028
  6.2.3 By Region - Global Non Hodgkin Lymphoma (NHL) Revenue Market Share, 2017-2028
6.3 North America
  6.3.1 By Country - North America Non Hodgkin Lymphoma (NHL) Revenue, 2017-2028
  6.3.2 US Non Hodgkin Lymphoma (NHL) Market Size, 2017-2028
  6.3.3 Canada Non Hodgkin Lymphoma (NHL) Market Size, 2017-2028
  6.3.4 Mexico Non Hodgkin Lymphoma (NHL) Market Size, 2017-2028
6.4 Europe
  6.4.1 By Country - Europe Non Hodgkin Lymphoma (NHL) Revenue, 2017-2028
  6.4.2 Germany Non Hodgkin Lymphoma (NHL) Market Size, 2017-2028
  6.4.3 France Non Hodgkin Lymphoma (NHL) Market Size, 2017-2028
  6.4.4 U.K. Non Hodgkin Lymphoma (NHL) Market Size, 2017-2028
  6.4.5 Italy Non Hodgkin Lymphoma (NHL) Market Size, 2017-2028
  6.4.6 Russia Non Hodgkin Lymphoma (NHL) Market Size, 2017-2028
  6.4.7 Nordic Countries Non Hodgkin Lymphoma (NHL) Market Size, 2017-2028
  6.4.8 Benelux Non Hodgkin Lymphoma (NHL) Market Size, 2017-2028
6.5 Asia
  6.5.1 By Region - Asia Non Hodgkin Lymphoma (NHL) Revenue, 2017-2028
  6.5.2 China Non Hodgkin Lymphoma (NHL) Market Size, 2017-2028
  6.5.3 Japan Non Hodgkin Lymphoma (NHL) Market Size, 2017-2028
  6.5.4 South Korea Non Hodgkin Lymphoma (NHL) Market Size, 2017-2028
  6.5.5 Southeast Asia Non Hodgkin Lymphoma (NHL) Market Size, 2017-2028
  6.5.6 India Non Hodgkin Lymphoma (NHL) Market Size, 2017-2028
6.6 South America
  6.6.1 By Country - South America Non Hodgkin Lymphoma (NHL) Revenue, 2017-2028
  6.6.2 Brazil Non Hodgkin Lymphoma (NHL) Market Size, 2017-2028
  6.6.3 Argentina Non Hodgkin Lymphoma (NHL) Market Size, 2017-2028
6.7 Middle East & Africa
  6.7.1 By Country - Middle East & Africa Non Hodgkin Lymphoma (NHL) Revenue, 2017-2028
  6.7.2 Turkey Non Hodgkin Lymphoma (NHL) Market Size, 2017-2028
  6.7.3 Israel Non Hodgkin Lymphoma (NHL) Market Size, 2017-2028
  6.7.4 Saudi Arabia Non Hodgkin Lymphoma (NHL) Market Size, 2017-2028
  6.7.5 UAE Non Hodgkin Lymphoma (NHL) Market Size, 2017-2028

7 PLAYERS PROFILES

7.1 F. Hoffmann-La Roche
  7.1.1 F. Hoffmann-La Roche Corporate Summary
  7.1.2 F. Hoffmann-La Roche Business Overview
  7.1.3 F. Hoffmann-La Roche Non Hodgkin Lymphoma (NHL) Major Product Offerings
  7.1.4 F. Hoffmann-La Roche Non Hodgkin Lymphoma (NHL) Revenue in Global Market (2017-2022)
  7.1.5 F. Hoffmann-La Roche Key News
7.2 Johnson & Johnson
  7.2.1 Johnson & Johnson Corporate Summary
  7.2.2 Johnson & Johnson Business Overview
  7.2.3 Johnson & Johnson Non Hodgkin Lymphoma (NHL) Major Product Offerings
  7.2.4 Johnson & Johnson Non Hodgkin Lymphoma (NHL) Revenue in Global Market (2017-2022)
  7.2.5 Johnson & Johnson Key News
7.3 Merck
  7.3.1 Merck Corporate Summary
  7.3.2 Merck Business Overview
  7.3.3 Merck Non Hodgkin Lymphoma (NHL) Major Product Offerings
  7.3.4 Merck Non Hodgkin Lymphoma (NHL) Revenue in Global Market (2017-2022)
  7.3.5 Merck Key News
7.4 Bristol Myers Squibb
  7.4.1 Bristol Myers Squibb Corporate Summary
  7.4.2 Bristol Myers Squibb Business Overview
  7.4.3 Bristol Myers Squibb Non Hodgkin Lymphoma (NHL) Major Product Offerings
  7.4.4 Bristol Myers Squibb Non Hodgkin Lymphoma (NHL) Revenue in Global Market (2017-2022)
  7.4.5 Bristol Myers Squibb Key News
7.5 Celgene
  7.5.1 Celgene Corporate Summary
  7.5.2 Celgene Business Overview
  7.5.3 Celgene Non Hodgkin Lymphoma (NHL) Major Product Offerings
  7.5.4 Celgene Non Hodgkin Lymphoma (NHL) Revenue in Global Market (2017-2022)
  7.5.5 Celgene Key News
7.6 Eli Lilly
  7.6.1 Eli Lilly Corporate Summary
  7.6.2 Eli Lilly Business Overview
  7.6.3 Eli Lilly Non Hodgkin Lymphoma (NHL) Major Product Offerings
  7.6.4 Eli Lilly Non Hodgkin Lymphoma (NHL) Revenue in Global Market (2017-2022)
  7.6.5 Eli Lilly Key News
7.7 GlaxoSmithKline
  7.7.1 GlaxoSmithKline Corporate Summary
  7.7.2 GlaxoSmithKline Business Overview
  7.7.3 GlaxoSmithKline Non Hodgkin Lymphoma (NHL) Major Product Offerings
  7.7.4 GlaxoSmithKline Non Hodgkin Lymphoma (NHL) Revenue in Global Market (2017-2022)
  7.7.5 GlaxoSmithKline Key News
7.8 Bayer
  7.8.1 Bayer Corporate Summary
  7.8.2 Bayer Business Overview
  7.8.3 Bayer Non Hodgkin Lymphoma (NHL) Major Product Offerings
  7.8.4 Bayer Non Hodgkin Lymphoma (NHL) Revenue in Global Market (2017-2022)
  7.8.5 Bayer Key News

8 CONCLUSION

9 APPENDIX

9.1 Note
9.2 Examples of Clients
9.3 Disclaimer

List Of Tables

LIST OF TABLES

Table 1. Non Hodgkin Lymphoma (NHL) Market Opportunities & Trends in Global Market
Table 2. Non Hodgkin Lymphoma (NHL) Market Drivers in Global Market
Table 3. Non Hodgkin Lymphoma (NHL) Market Restraints in Global Market
Table 4. Key Players of Non Hodgkin Lymphoma (NHL) in Global Market
Table 5. Top Non Hodgkin Lymphoma (NHL) Players in Global Market, Ranking by Revenue (2021)
Table 6. Global Non Hodgkin Lymphoma (NHL) Revenue by Companies, (US$, Mn), 2017-2022
Table 7. Global Non Hodgkin Lymphoma (NHL) Revenue Share by Companies, 2017-2022
Table 8. Global Companies Non Hodgkin Lymphoma (NHL) Product Type
Table 9. List of Global Tier 1 Non Hodgkin Lymphoma (NHL) Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Non Hodgkin Lymphoma (NHL) Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 11. By Type – Global Non Hodgkin Lymphoma (NHL) Revenue, (US$, Mn), 2021 & 2028
Table 12. By Type - Non Hodgkin Lymphoma (NHL) Revenue in Global (US$, Mn), 2017-2022
Table 13. By Type - Non Hodgkin Lymphoma (NHL) Revenue in Global (US$, Mn), 2023-2028
Table 14. By Application – Global Non Hodgkin Lymphoma (NHL) Revenue, (US$, Mn), 2021 & 2028
Table 15. By Application - Non Hodgkin Lymphoma (NHL) Revenue in Global (US$, Mn), 2017-2022
Table 16. By Application - Non Hodgkin Lymphoma (NHL) Revenue in Global (US$, Mn), 2023-2028
Table 17. By Region – Global Non Hodgkin Lymphoma (NHL) Revenue, (US$, Mn), 2021 & 2028
Table 18. By Region - Global Non Hodgkin Lymphoma (NHL) Revenue (US$, Mn), 2017-2022
Table 19. By Region - Global Non Hodgkin Lymphoma (NHL) Revenue (US$, Mn), 2023-2028
Table 20. By Country - North America Non Hodgkin Lymphoma (NHL) Revenue, (US$, Mn), 2017-2022
Table 21. By Country - North America Non Hodgkin Lymphoma (NHL) Revenue, (US$, Mn), 2023-2028
Table 22. By Country - Europe Non Hodgkin Lymphoma (NHL) Revenue, (US$, Mn), 2017-2022
Table 23. By Country - Europe Non Hodgkin Lymphoma (NHL) Revenue, (US$, Mn), 2023-2028
Table 24. By Region - Asia Non Hodgkin Lymphoma (NHL) Revenue, (US$, Mn), 2017-2022
Table 25. By Region - Asia Non Hodgkin Lymphoma (NHL) Revenue, (US$, Mn), 2023-2028
Table 26. By Country - South America Non Hodgkin Lymphoma (NHL) Revenue, (US$, Mn), 2017-2022
Table 27. By Country - South America Non Hodgkin Lymphoma (NHL) Revenue, (US$, Mn), 2023-2028
Table 28. By Country - Middle East & Africa Non Hodgkin Lymphoma (NHL) Revenue, (US$, Mn), 2017-2022
Table 29. By Country - Middle East & Africa Non Hodgkin Lymphoma (NHL) Revenue, (US$, Mn), 2023-2028
Table 30. F. Hoffmann-La Roche Corporate Summary
Table 31. F. Hoffmann-La Roche Non Hodgkin Lymphoma (NHL) Product Offerings
Table 32. F. Hoffmann-La Roche Non Hodgkin Lymphoma (NHL) Revenue (US$, Mn), (2017-2022)
Table 33. Johnson & Johnson Corporate Summary
Table 34. Johnson & Johnson Non Hodgkin Lymphoma (NHL) Product Offerings
Table 35. Johnson & Johnson Non Hodgkin Lymphoma (NHL) Revenue (US$, Mn), (2017-2022)
Table 36. Merck Corporate Summary
Table 37. Merck Non Hodgkin Lymphoma (NHL) Product Offerings
Table 38. Merck Non Hodgkin Lymphoma (NHL) Revenue (US$, Mn), (2017-2022)
Table 39. Bristol Myers Squibb Corporate Summary
Table 40. Bristol Myers Squibb Non Hodgkin Lymphoma (NHL) Product Offerings
Table 41. Bristol Myers Squibb Non Hodgkin Lymphoma (NHL) Revenue (US$, Mn), (2017-2022)
Table 42. Celgene Corporate Summary
Table 43. Celgene Non Hodgkin Lymphoma (NHL) Product Offerings
Table 44. Celgene Non Hodgkin Lymphoma (NHL) Revenue (US$, Mn), (2017-2022)
Table 45. Eli Lilly Corporate Summary
Table 46. Eli Lilly Non Hodgkin Lymphoma (NHL) Product Offerings
Table 47. Eli Lilly Non Hodgkin Lymphoma (NHL) Revenue (US$, Mn), (2017-2022)
Table 48. GlaxoSmithKline Corporate Summary
Table 49. GlaxoSmithKline Non Hodgkin Lymphoma (NHL) Product Offerings
Table 50. GlaxoSmithKline Non Hodgkin Lymphoma (NHL) Revenue (US$, Mn), (2017-2022)
Table 51. Bayer Corporate Summary
Table 52. Bayer Non Hodgkin Lymphoma (NHL) Product Offerings
Table 53. Bayer Non Hodgkin Lymphoma (NHL) Revenue (US$, Mn), (2017-2022)

List Of Figures

LIST OF FIGURES

Figure 1. Non Hodgkin Lymphoma (NHL) Segment by Type in 2021
Figure 2. Non Hodgkin Lymphoma (NHL) Segment by Application in 2021
Figure 3. Global Non Hodgkin Lymphoma (NHL) Market Overview: 2021
Figure 4. Key Caveats
Figure 5. Global Non Hodgkin Lymphoma (NHL) Market Size: 2021 VS 2028 (US$, Mn)
Figure 6. Global Non Hodgkin Lymphoma (NHL) Revenue, 2017-2028 (US$, Mn)
Figure 7. The Top 3 and 5 Players Market Share by Non Hodgkin Lymphoma (NHL) Revenue in 2021
Figure 8. By Type - Global Non Hodgkin Lymphoma (NHL) Revenue Market Share, 2017-2028
Figure 9. By Application - Global Non Hodgkin Lymphoma (NHL) Revenue Market Share, 2017-2028
Figure 10. By Region - Global Non Hodgkin Lymphoma (NHL) Revenue Market Share, 2017-2028
Figure 11. By Country - North America Non Hodgkin Lymphoma (NHL) Revenue Market Share, 2017-2028
Figure 12. US Non Hodgkin Lymphoma (NHL) Revenue, (US$, Mn), 2017-2028
Figure 13. Canada Non Hodgkin Lymphoma (NHL) Revenue, (US$, Mn), 2017-2028
Figure 14. Mexico Non Hodgkin Lymphoma (NHL) Revenue, (US$, Mn), 2017-2028
Figure 15. By Country - Europe Non Hodgkin Lymphoma (NHL) Revenue Market Share, 2017-2028
Figure 16. Germany Non Hodgkin Lymphoma (NHL) Revenue, (US$, Mn), 2017-2028
Figure 17. France Non Hodgkin Lymphoma (NHL) Revenue, (US$, Mn), 2017-2028
Figure 18. U.K. Non Hodgkin Lymphoma (NHL) Revenue, (US$, Mn), 2017-2028
Figure 19. Italy Non Hodgkin Lymphoma (NHL) Revenue, (US$, Mn), 2017-2028
Figure 20. Russia Non Hodgkin Lymphoma (NHL) Revenue, (US$, Mn), 2017-2028
Figure 21. Nordic Countries Non Hodgkin Lymphoma (NHL) Revenue, (US$, Mn), 2017-2028
Figure 22. Benelux Non Hodgkin Lymphoma (NHL) Revenue, (US$, Mn), 2017-2028
Figure 23. By Region - Asia Non Hodgkin Lymphoma (NHL) Revenue Market Share, 2017-2028
Figure 24. China Non Hodgkin Lymphoma (NHL) Revenue, (US$, Mn), 2017-2028
Figure 25. Japan Non Hodgkin Lymphoma (NHL) Revenue, (US$, Mn), 2017-2028
Figure 26. South Korea Non Hodgkin Lymphoma (NHL) Revenue, (US$, Mn), 2017-2028
Figure 27. Southeast Asia Non Hodgkin Lymphoma (NHL) Revenue, (US$, Mn), 2017-2028
Figure 28. India Non Hodgkin Lymphoma (NHL) Revenue, (US$, Mn), 2017-2028
Figure 29. By Country - South America Non Hodgkin Lymphoma (NHL) Revenue Market Share, 2017-2028
Figure 30. Brazil Non Hodgkin Lymphoma (NHL) Revenue, (US$, Mn), 2017-2028
Figure 31. Argentina Non Hodgkin Lymphoma (NHL) Revenue, (US$, Mn), 2017-2028
Figure 32. By Country - Middle East & Africa Non Hodgkin Lymphoma (NHL) Revenue Market Share, 2017-2028
Figure 33. Turkey Non Hodgkin Lymphoma (NHL) Revenue, (US$, Mn), 2017-2028
Figure 34. Israel Non Hodgkin Lymphoma (NHL) Revenue, (US$, Mn), 2017-2028
Figure 35. Saudi Arabia Non Hodgkin Lymphoma (NHL) Revenue, (US$, Mn), 2017-2028
Figure 36. UAE Non Hodgkin Lymphoma (NHL) Revenue, (US$, Mn), 2017-2028
Figure 37. F. Hoffmann-La Roche Non Hodgkin Lymphoma (NHL) Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 38. Johnson & Johnson Non Hodgkin Lymphoma (NHL) Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 39. Merck Non Hodgkin Lymphoma (NHL) Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 40. Bristol Myers Squibb Non Hodgkin Lymphoma (NHL) Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 41. Celgene Non Hodgkin Lymphoma (NHL) Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 42. Eli Lilly Non Hodgkin Lymphoma (NHL) Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 43. GlaxoSmithKline Non Hodgkin Lymphoma (NHL) Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 44. Bayer Non Hodgkin Lymphoma (NHL) Revenue Year Over Year Growth (US$, Mn) & (2017-2022)